Nutex Health Inc.

Greetings and welcome to NewTex Health second quarter 2024 financial results conference call. At this time, all participants are on a listen-only mode. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Jennifer Rodriguez. Thank you. You may begin.

Welcome to the NewTex Health second quarter 2024 earnings conference call. Today's call is being recorded. With me this morning is our Chairman and CEO, Dr. Tom Vo, CFO John Bates, President Dr. Warren Hosinian, and COO Josh Titilio. Our team will provide some prepared remarks and then we'll take questions. Before I turn the call over to Dr. Vo, Let me remind everyone that today's call may contain forward-looking statements that are based on management's current expectations, numerous risks, uncertainties, and other factors that may cause actual results to differ materially from those that might be expressed today. More information on forward-looking statements and these factors are listed in Thursday's press release and in our various SEC filings. On this morning's call, we may reference measures such as adjusted EBITDA which is a non-GAAP financial measure. A table providing supplemental information on adjusted EBITDA and reconciling net loss attributable to NewTex Health, Inc. is included in the press release and form 10-K filed earlier this week. This morning's call is being recorded, and a replay of the call will be available later today. With that, I'll now turn the call over to Dr. Tom Bowe, our Founder and Chief Executive Officer.

Jennifer, thank you. Good morning to everyone, and thank you for joining the call.